MarketBeat provided consensus ratings for MACOM as Susquehanna dropped its price objective and Needham & Company increased its target and gave a buy rating.
2 reports, 2 independent
Updated Oct 24
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat provided consensus ratings for MACOM as Susquehanna dropped its price objective and Needham & Company increased its target and gave a buy rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
MarketBeat
American personal finance blog
-
Susquehanna
railroad station in Susquehanna, Pennsylvania, United States
-
Needham & Company
American independent investment bank and asset management firm
Related events
- MarketBeat provided average ratings and consensus target prices for Pacira BioSciences, while Needham and Royal Bank of Canada issued rating updates.
- MarketBeat provided an average rating and price target for National Steel Company.
- MarketBeat provided average ratings and target prices, while Jefferies Financial Group began coverage with a buy rating for Crane NXT.
- MarketBeat reported average rating data as Barclays raised its price target and TD Cowen raised its price target for Brinker International.
- MarketBeat provided stock average ratings while Leerink Partners upgraded and Barclays raised its price objective for Summit Therapeutics.